Detalhe da pesquisa
1.
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma.
J Proteome Res
; 23(2): 749-759, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266179
2.
Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma.
Gynecol Oncol
; 187: 92-97, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735145
3.
Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study.
Gynecol Oncol
; 185: 95-100, 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377763
4.
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis.
Int J Gynecol Cancer
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548312
5.
Sustainability of an enhanced recovery pathway after minimally invasive gynecologic oncology surgery.
Int J Gynecol Cancer
; 34(5): 738-744, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531541
6.
Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer.
J Surg Oncol
; 127(3): 465-472, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350138
7.
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer.
Int J Gynecol Cancer
; 33(7): 1077-1082, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015756
8.
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.
Can J Surg
; 66(3): E310-E320, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369443
9.
Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer.
Int J Mol Sci
; 24(18)2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762691
10.
Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysis.
Gynecol Oncol
; 164(1): 212-220, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756470
11.
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer.
Gynecol Oncol
; 167(3): 417-422, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191644
12.
Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer.
Gynecol Oncol
; 166(3): 453-459, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820987
13.
Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancer.
J Surg Oncol
; 125(4): 736-746, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34786711
14.
Predicting recurrence and recurrence-free survival in high-grade endometrial cancer using machine learning.
J Surg Oncol
; 126(6): 1096-1103, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819161
15.
Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project.
Int J Gynecol Cancer
; 32(4): 457-465, 2022 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987097
16.
Cost-effectiveness of maintenance hormonal therapy in patients with advanced low grade serous ovarian cancer.
Gynecol Oncol
; 160(1): 206-213, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032821
17.
The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma.
Gynecol Oncol
; 162(3): 702-706, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256977
18.
Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic review.
Gynecol Oncol
; 163(1): 209-214, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34325937
19.
Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center.
Gynecol Oncol
; 162(1): 12-17, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941382
20.
The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
Gynecol Oncol
; 162(1): 97-106, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858678